| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000225265.1 |
Cytarabine |
Breast invasive carcinoma |
0.023048521 |
Resistant |
| ENSG00000225265.1 |
Cytarabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.043836262 |
Resistant |
| ENSG00000225265.1 |
Cytarabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.049855931 |
Resistant |
